Dong-A Socio Holdings posted a 31 percent jump in first-quarter operating profit, powered by an 854 percent surge at ...

Korean patients with atopic dermatitis (AD) -- the most common form of eczema -- aren’t short on complaints, but for many, it ...

Researchers at Ulsan National Institute of Science and Technology (UNIST) said they have developed a new robotic technology ...

Korea’s ambitious plan to raise a K-Bio Vaccine Fund worth 1 trillion won ($703 million) for biotech innovation by 2025 is ...

Despite growing concerns from the medical community about inadequate training, lawmakers are continuing to propose bills ...

The Korean government is taking action to address regulatory bottlenecks that have made it difficult for rapidly evolving ...

Amorepacific Holdings reported robust financial results for the first quarter of 2025, driven by the continued success of its ...

Ubix Therapeutics is one of the leading companies in Korea that has secured technology transfer and in-house clinical ...

The total sales of Korea’s bio-health industry edged down 0.7 percent year-on-year to 133 trillion won ($93.3 billion) in 2023, while revenue in the pharmaceutical sector rose to 53.8 trillion won, go ...

Hanmi Pharmaceutical stumbled in the first quarter of 2025 as weak overseas performance dragged down group earnings, but back home, its core drug business roared back to life.Operating profit dropped ...

Ildong Pharmaceutical is challenging Boehringer Ingelheim’s blockbuster idiopathic pulmonary fibrosis (IPF) drug, Ofev ...

Roen Surgical, a Korean robotic surgery platform company, said Tuesday it has unveiled Zamenix, the “world's first” ...